SecBot SecBot
PRESS-RELEASE ·Filed Nov 4, 2026

PRAX

Praxis Precision Medicines, Inc.
NEUTRAL
Impact 1/10
Horizonimmediate Processed12d 7h ago WireGlobeNewswire
Press release · Activist
Actionable Insight • Neutral

This is a standard inducement grant for new hires with no material financial impact. Monitor for any future updates on employee retention or broader equity compensation plans, but no immediate action warranted.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$262.59
T+0 close · Nov 4, 2026 · via day close
Latest settled
+23.68%
T+5 · $324.76 · next T+20 in 17d
Vs SPY
+20.39%
α at T+5
Latest observation
+19.23%
T+6 · FF3 residual α
  1. T+0 · Nov 5 $262.59entry
  2. T+1 · 11d ago +5.72%α +5.41% · $277.62
  3. T+5 · 5d ago +23.68%α +20.39% · $324.76
  4. T+7 · todayOpen
  5. T+20 · in 17d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Praxis Precision Medicines granted 23,219 restricted stock units to 59 new non-executive employees under its 2024 Inducement Plan, as inducements material to their employment. The awards vest over four years. This is a routine equity grant for new hires, immaterial relative to the company's $7.6B market cap.

Key Facts

  • 23,219 restricted stock units granted to 59 new non-executive employees
  • Awards vest in four equal annual installments
  • Granted under the 2024 Inducement Plan per Nasdaq Listing Rule 5635(c)(4)
  • Company market cap is $7.6B, making the grant de minimis

Financial Impact

23,219 shares granted; at current market cap of $7.6B, the value is negligible (less than 0.01% of shares outstanding)

dilution

Risk Factors

  • No material risks identified from this routine grant

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
89% bullish (27 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3395771

Track record

16 reports on PRAX

Performance horizon

5 of 7 bullish or bearish reports moved the stock their way by T+60. Best: +15.73% at T+60 after the Jun 29, 2026 report. 6 of 7 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Bearish 4/10 Entry $317.69 Now $310.27 +2.34% settles Feb 12
  2. Nov 12, 20264d ago 8-K Neutral 4/10 Entry $328.13 Now $310.27 −5.44% settles Feb 11
  3. Nov 9, 20267d ago Press Release Neutral 4/10 Entry $332.97 Now $310.27 −6.82% settles Feb 5
  4. Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $262.59 Now $310.27 +18.16% settles Feb 3
  5. Nov 4, 202612d ago Press Release Neutral 1/10 Viewing Entry $262.59 Now $310.27 +18.16% settles Feb 3
  6. Oct 29, 202618d ago Institutional Cluster Neutral 2/10 Entry $288.62 Now $310.27 +7.50% settles Jan 27
  7. Jun 29, 202620w ago 8-K Bearish 6/10 Entry $334.79 to $282.12 Now $310.27 +7.32% ▲ +15.73% +18.55% vs SPY
  8. Jun 11, 202622w ago Institutional Cluster Mixed 4/10 Entry $247.98 to $351.81 Now $310.27 +25.12% ▲ +41.87% +37.47% vs SPY
  9. Jun 2, 202623w ago Press Release Neutral 1/10 Entry $278.93 to $367.85 Now $310.27 +11.24% ▲ +31.88% +29.38% vs SPY
  10. May 7, 202627w ago Press Release Bullish 8/10 Entry $333.28 to $305.51 Now $310.27 −6.90% ▼ −8.33% −12.17% vs SPY
Showing 10 of 16

US Market Status

Market Closed · Opens Wed (9h 50m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 4, 2026